Lupin receives US FDA tentative approval for raltegravir tablets, USP: Our Bureau, Mumbai Friday, November 8, 2024, 17:45 Hrs [IST] Global pharma major Lupin Limited (Lupin) annou ...
Drugmaker Lupin and a unit of Aurobindo Pharma are recalling products from the American market ... As per the latest Enforcement Report issued by the US Food and Drug Administration (USFDA ...
Dr Reddy's Laboratories and Lupin are recalling products in the US due to manufacturing issues, as per the US Food and Drug Administration (USFDA). Dr Reddy's Laboratories Inc, a subsidiary of ...
Lupin has obtained the Food and Drug Administration’s permission for two new generics and the company has launched an additional generic. The FDA approved Bromfenac Ophthalmic Solution ...
Operationally, the company's EBITDA or Earnings Before Interest, Taxes, Depreciation, and Amortization is seen jumping 25 per cent YoY to Rs 1,149 crore, from Rs 918 crore reported in the same quarter ...
Lupin Ltd (BOM:500257) reports robust financial performance with significant gains in India and US markets, while navigating competitive challenges and FDA compliance issues.
“Through the signature of this collaboration with Lupin, Scope is expanding its footprint in Latin America for its OPTASE range. Mexico is clearly a country of strategic importance for Scope where our ...
A series of animated action-adventure films directed by Takeshi Koike (animation director and character designer for "The Woman Called Fujiko Mine"). Each centers on one of Lupin's long-time ...